The Asia-Pacific Guidelines for ‘Índigo’ interstitial laser coagulation in the management of benign prostatic hyperplasia

References

• Holtgrewe H L, Ackermann R, Bay-Nielsen H, et al (1993) Proceedings of the 2nd lnternational consultation on benign prostatic hyperplasia (BPH), Paris, June, 27–301993. Scientific Communication International Ltd., Jersey, Channel Island, 37–44
   Google Scholar
• Te A E, Kaplan S A. Prostatic endoprosthetics. Textbook of benign prostatic hyperplasia, R Kirby, J D McConnell, J M Fitzpatrick, et al. ISIS Medical Media, Oxford 1996; 453–61
   Google Scholar
• Madersbacher S, Kratzik C, Susani M, Marberger M. Tissue ablation in benign prostatic hyperplasia with high intensity focused ultrasound. J Urol 1994; 152: 1956–61
   PubMed Web of Science ®Google Scholar
• Schulman C C, Vanden Bossche M. Hyperthermia and thermotherapy of benign prostatic hyperplasia: a critical review. Eur Urol 1993; 23(suppl)53–9
   Google Scholar
• Schulman C C, Zlotta A R. Early clinical experience with a new procedure for treatment of BPH (TUN4). Urology 1995; 45: 28–33
   PubMed Web of Science ®Google Scholar
• Kaplan S A, Te A E. Transurethral electrovaporization of the prostate: a novel method for treating men with benign prostatic hyperplasia. Urology 1995; 45: 566–72
   PubMed Web of Science ®Google Scholar
• Costello A J, Shaffer B S, Crowe H R. Second-generation delivery system for laser prostatic ablation. Urology 1994; 43: 262–6
   PubMed Web of Science ®Google Scholar
• Narayan P, Tewari A, Schalow E, et al. Transurethral evaporation of the prostate for treatment of benign prostatic hyperplasia: results in 168 patients with 12 months of follow up. J Urol 1997; 157: 1309–12
   Google Scholar
• Costello A J, Bowsher W G, Bolton D M, et al. Laser ablation of prostate in patients with benign prostatic hypertrophy. Br J Urol 1992; 69: 603–8
   PubMedGoogle Scholar
• Muschter R, de la Rosette J JMCH, Whitfield H, et al. Initial human clinical experience with diode interstitial treatment of benign prostatic hyperplasia. Urology 1996; 48: 223–8
   Google Scholar
• Muschter R, Hofstetter A, Hessel S, et al. Interstitial laser prostatectomy-experimental and first clinical results. J Urol 1992; 147: 346, [abstract]
   Google Scholar
• Muschter R, Hofstetter A. Interstitial laser therapy outcomes in benign prostatic hyperplasia. J Endourol 1995; 9: 129–35
   PubMed Web of Science ®Google Scholar
• Williams J C. Interstitial laser coagulation of the prostate. Tech Urol 1996; 2: 130–5
   Google Scholar
• de la Rosette J JMCH, Muschter R, Lopez M A, Gillatt D. Interstitial laser coagulation in the treatment of benign prostatic hyperplasia using a diode-laser system with temperature feedback. Br J Urol 1997; 80: 433–8
   PubMedGoogle Scholar
• Arai Y, Kanba T, Ishitoya S, et al. Interstitial laser coagulation for benign prostatic hyperplasia: preliminary clinical results. lnt J Urol 1995; 2: 104–9
   Google Scholar
• Arai Y, Lshitoya S, Okubo K, Suzuki Y. Transurethral interstitial laser coagulation for benign prostatic hyperplasia: treatment outcome and quality of life. Br J Urol 1996; 77: 93–8
   Google Scholar
• Arai Y, Okubo K, Okada T, et al. Interstitial laser coagulation for management of benign prostatic hyperplasia: a Japanese experience. J Urol 1998; 159: 1961–5
   PubMed Web of Science ®Google Scholar
• McNicholas T A, Al-Sudani M. Interstitial laser coagulation. Textbook of benign prostatic hyperplasia, R Kirby, J D McConnell, J M Fitzpatrick, et al. ISIS Medical Media, Oxford 1996; 389–-97
   Google Scholar
• McNicholas T A, Aslam M, Lynch M J, O'Donoghue N. Interstitial laser coagulation for the treatment of urinary outflow obstruction. J Urol 1993; 149: 465, [abstract]
   Google Scholar
• Muschter R, Hofstetter A. Technique and results of interstitial laser coagulation. World J Urol 1995; 13: 109–14
   PubMed Web of Science ®Google Scholar
• Muschter R, Perlmutter A P, Hessel S, Hofstetter A. Interstitial laser coagulation of benign prostatic hyperplasia: three years' experience. Application of newer forms of therapeutic energy in urology, M Marberger. ISIS Medical Media, Oxford 1995; 179–-87
   Google Scholar
• Chang S C, Cheng H L, Tsui K H. hdigo® 830e interstitial laser coagulation for the treatment of BPH: Ultrasonographic appearance, advantages and limitations. Asian J Surg 1999; 22: 245–51
   Google Scholar
• Te Slaa E, de la Rosette J JMCH. Lasers in the treatment of benign prostatic obstruction: past, present and future. Eur Urol 1996; 30: 1–10
   Google Scholar
• Conn R L, Kursh E D, Williams JC, et al. One year outcoines of interstitial laser coagulation of the prostate in 100 men: a multicenter experience. J Urol 1999; 161: 390, [abstract]
   Google Scholar
• Costello A J, Agarwal D K, Crowe H R, Lynch W J. Evaluation of interstitial diode laser therapy for treatment of benigri prostatic hyperplasia. Tech Urol 1999; 5: 202–6
   Google Scholar
• Daehlin L, Hedlund H. Interstitial laser coagulation in patients with lower urinary tract symptoms from benign prostatic obstruction: treatment under sedoanalgesia with oressure-flow evaluation. BJU Int 1999; 84: 628–36
   PubMed Web of Science ®Google Scholar
• Greenberger M, Steiner M S. The University of Tennessee experience with the Indigo 830e laser device for the minimally invasive treatment of benign prostatic hyperplasia: interim analysis. World J Urol 1998; 16: 386–91
   PubMed Web of Science ®Google Scholar
• Muschter R., Schneede R, Muller-Lisse U, et al. Interstitial Nd:YAG laser therapy of the prostate: long-term results and new developments. J Urol 1997; 157: 42, [abstract]
   Google Scholar
• Whitfield H N. A randomized prospective multicenter study evaluating the efficacy of interstitial laser coagulation. J Urol 1996; 155: 318, [abstract]
   Google Scholar
• Williams J C. Interstitial laser coagulation of the prostate: introduction of a volume-based treatment formula with 12–month follow-Lip. World J Urol 1998; 16: 392–5
   PubMed Web of Science ®Google Scholar
• Williaims J C, Conn R L, Kursh E D, et al. One and two year outcomes of interstitial laser coagulation of the prostate in 250 men: a multicenter experience with the indigo 830e®. J Urol 2000; 163: 271, [abstract]
   Google Scholar
• Henkel T O, Niedergethmann M, Alken P. Laser induced interstitial thermotherapy (LITT): in vitro and in vivo studies. J Endourol 1995; 9: S56, [abstract]
   Google Scholar
• Horninger W, Janetschet G, Pointner J, et al. Are TULIP interstitial laser and contact laser superior to TURP?. J Urol 1995; 153: 413, [abstract]
   Google Scholar
• Martov A G, Kilchukov Z I. Interstitial laser induced coagulation of BPH: 6 months follow-up. J Endourol 1996; 10: S191, [abstract]
   Google Scholar
• Roggan A, Haridke A, Miller K, Muller G. Laser induced interstitial thermotherapy of benign prostatic hyperplasia — basic investigations and first clinical results. Min lnvasive Med 1994; 5: 55–63
   Google Scholar
• Schettini M, Diana M, Fortunato P, et al. Results of interstitial laser coagulation of the prostate. J Endourol 1996; 10: S191, [abstract]
   Google Scholar
• Muscqter R, Sroka R, Perlmutter AP, et al. High power interstitial laser coagulation of benign prostatic hyperplasia. J Endourol 1996; 10: S197, [abstract]
   Google Scholar
• Perlmutter A P, Muschter R. Interstitial laser prostatectorny. Map Clin Proc 1998; 73: 903–7
   PubMedGoogle Scholar
• Barry M J, Fowler FJ, Jr, O'Leary MP, et al. The American Uroloqrcal Association symptom index for benign prostatic hyperplasia. J Urol 1992; 148: 1549–57
   PubMed Web of Science ®Google Scholar
• Denis L, McConnell J, Yoshida O, (1998) Recommendation of the International Scientific Committee: the evaluation and treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction. Proceedings of the 4th international consultation on benign prostatic hyperplasia (BPH), Paris, July, 2–51997, L Denis, K Griffith, S Khoury, et al. Health Publication Ltd., Plymouth, 669–84
   Google Scholar
• Cockett A TK, Aso Y, Denis L, (1993) Recommendations of the International Consensus Committee Concerning: 1. Prostate symptom score and quality of life assessment. Proceedings of the 2nd international consultation on benign prostatic hyperplasia (BPH), Paris, June, 27–301993, A TK Cockett, S Khoury, Y Aso, et al. Channel Island: Scientific Communication International Ltd, Jersey, 553–5
   Google Scholar
• Koyanigi T, Artibani W, Correa R, (1998) Initial evaluation of men with lower urinary tract symptoms. Proceedings of the 4th international consultation on benign prostatic hyperplasia (BPH), Paris, July, 2–51997, L Denis, K Griffith, S Khoury, et al. Health Publication Ltd, Plymouth, 181–264
   Google Scholar
• Watson G. Laser prostatectomy: where are we now, and where should we be going?. J Endourol 1995; 9: 199–203
   PubMed Web of Science ®Google Scholar
• Strasser H, Janetschek G, Horninger W, Bartsch G. Three-dimensional sonographic guidance for interstitial laser therapy in benign hyperplasia. J Endourol 1995; 9: 497–501
   Google Scholar
• Mueller-Lisse U G, Heuck A F, Schneede P, et al. Postoperative MRI in patients undergoing interstitial laser coagulation thermotherapy of benign prostatic hyperplasia. J Comput Assist Tomog 1996; 20: 273–8
   Google Scholar
• Costello A J, Lusaya D G, Crowe H R. Transurethral laser ablation of the prostate: long-term results. World J Urol 1995; 13: 119–22
   Google Scholar
• Roos N P, Wennberg J E, Malenka D J, et al. Motality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med 1989; 320: 1120–4
   PubMed Web of Science ®Google Scholar
• Schulze H. TULIP: Transurethral ultrasound-guided laser induced prostatectomy. World J Urol 1995; 13: 94–7
   Google Scholar
• Norris J P, Norris D M, Lee R D, Rubenstein M A. Visual laser ablation of the prostate: clinical experience in 108 patients. J Urol 1993; 150: 1612–14
   PubMedGoogle Scholar
• Muschter R. Interstitial laser therapy. Curr Opin Urol 1996; 6: 33–8
   Google Scholar
• Krautschick A W, Kohrmann K U, Henkel T O, et al. Interstitial laser coagulation in benign prostatic hyperplasia: a critical evaluation after 2 years of follow-up. Urol lnt 1999; 62: 76–80
   Google Scholar
• Holtgrewe H L. Economics of benign prostatic hyperplasia. Textbook of benign prostatic hyperplasia, R Kirby, J D McConnell, J M Fitzpatrick, et al. lsis Medical Media, Oxford 1996; 527–-36
   Google Scholar
• Zlotta A R, Schulman C C. Interstitial laser coagulation for the treatment of benign prostatic hyperplasia using local anaesthesia only. BJU lnt 1999; 83: 341–2
   Google Scholar